Loading...
TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in Chinese city of Wuhan has caused around 906,092 deaths and 28,040,853 confirmed cases worldwide (https://covid19.who.int/, 11 September 2020). In a life-threatening situation, where there is no specific and licensed...
Na minha lista:
| Udgivet i: | Arab J Chem |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Published by Elsevier B.V. on behalf of King Saud University.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7527303/ https://ncbi.nlm.nih.gov/pubmed/34909057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.arabjc.2020.09.037 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|